Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Medtronic
Boehringer Ingelheim
Mallinckrodt
McKesson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Methoxsalen - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

Drug Prices for methoxsalen

See drug prices for methoxsalen

Recent Clinical Trials for methoxsalen

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Joseph Ahmed FoundationPhase 2
Tyme, IncPhase 2
Sarcoma Oncology Research Center, LLCPhase 2

See all methoxsalen clinical trials

Pharmacology for methoxsalen
Medical Subject Heading (MeSH) Categories for methoxsalen
Synonyms for methoxsalen
12692-94-3
298-81-7
298M817
4CN-0934
5-19-06-00015 (Beilstein Handbook Reference)
5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, .delta.-lactone
5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, delta-lactone
5-Demethoxyisoimpinellin
6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone
7-Furocoumarin
7H-Furo(3,2-G)(1)benzopyran-7-one, 9-methoxy-
7H-Furo[3, 9-methoxy-
7H-Furo[3,2-g][1]benzopyran-7-one, 9-methoxy-
8-Methoxy
8-Methoxy-(furano-3'.2':6.7-coumarin)
8-Methoxy-[furano-3'.2':6.7-coumarin]
8-methoxy-[furano-3''.2'':6.7-coumarin]
8-Methoxy-2',3',6,7-furocoumarin
8-Methoxy-2',6,7-furocoumarin
8-methoxy-2'',3'',6,7-furocoumarin
8-Methoxy-4',5',6,7-furocoumarin
8-Methoxy-4',5':6,7-furocoumarin
8-Methoxy-4',6,7-furocoumarin
8-methoxy-4'',5'':6,7-furocoumarin
8-Methoxy-6,7-furanocoumarin
8-Methoxy(furano-3'.2':6.7-coumarin)
8-Methoxyfuranocoumarin
8-Methoxypsoralen
8-METHOXYPSORALEN + UVA (SEE ALSO C55903)
8-Methoxypsoralen with ultraviolet A therapy
8-Methoxypsoralen, 99%
8-Methoxypsoralen, analytical standard
8-Methoxypsoralene
8-MOP
8-MOP ; Methoxsalen
8-MP
8MO
9-(methyloxy)-7H-furo[3,2-g]chromen-7-one
9-metho xy-7H-furo(3,2-g)benzopyran-7-one
9-METHOXY-2H-FURO[3,2-G]CHROMEN-2-ONE
9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one
9-Methoxy-7H-furo(3,2-g)benzopyran-7-one
9-Methoxy-7H-furo[3,2- g][1]benzopyran-7-one
9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one
9-Methoxy-7H-furo[3,2-g]chromen-7-one
9-Methoxy-7H-furo[3,2-g]chromen-7-one #
9-methoxyfurano[3,2-g]chromen-2-one
9-Methoxyfuro(3,2-g)chromen-7-one
9-Methoxyfuro[3,2-g][1]benzopyran-7-one
9-methoxyfuro[3,2-g]chromen-7-one
9-Methoxypsoralen
A1783/0075596
AB00052042_16
AB00052042_17
AB00052042-14
AB00052042-15
AB2000388
AC-4259
AC1L1HFY
ACon1_000174
AJ-39565
AK111265
AKOS000277012
AM84906
Ammodin
Ammoidin
AN-12178
API0008254
AX8020056
BC204608
BC4157549
BCP28212
BDBM50041234
BG0479
BPBio1_000680
BRD-K63430059-001-03-2
BRD-K63430059-001-06-5
BRD-K63430059-001-09-9
BRN 0196453
BSPBio_000618
BSPBio_001997
C-11618
C01864
CAS-298-81-7
CC-30277
CCG-36366
CCRIS 2083
CHEBI:18358
CHEMBL416
CM-131
CPD000071170
CS-1983
D00139
DB00553
Deltapsoralen
DivK1c_000763
Dltasoralen
DS-5159
DSSTox_CID_830
DSSTox_GSID_20830
DSSTox_RID_75816
DTXSID8020830
EINECS 206-066-9
EN300-52504
FT-0082222
FT-0602101
Geroxalen
GP5578
HMS1569O20
HMS1920N05
HMS2091D20
HMS2096O20
HMS2269P03
HMS3259L13
HMS3655B05
HMS502G05
HSDB 2505
HY-30151
I06-0695
IDI1_000763
J10204
JC10026
Jsp005650
KBio1_000763
KBio2_001503
KBio2_004071
KBio2_006639
KBio3_001497
KBioGR_000543
KBioSS_001503
KS-00000J91
LS-68
MCULE-2500932325
MEGxp0_000095
Meladinin
Meladinin (VAN)
Meladinine
Meladoxen
Meloxine
Methoxa-Dome
Methoxalen
Methoxaten
Methoxsalen (JP17/USP)
Methoxsalen (Oxsoralen)
Methoxsalen [BAN:JAN]
Methoxsalen [USP:BAN:JAN]
Methoxsalen plus ultraviolet radiation
Methoxsalen with ultra-violet A theraphy
Methoxsalen, 8-
Methoxsalen, United States Pharmacopeia (USP) Reference Standard
Methoxsalene
Methoxy-8-psoralen
Metoxaleno
MFCD00005009
MLS000062633
MLS002303011
MolPort-000-696-480
N1305
NC00652
NCGC00016418-01
NCGC00016418-02
NCGC00016418-03
NCGC00016418-04
NCGC00016418-05
NCGC00016418-06
NCGC00016418-07
NCGC00016418-08
NCGC00016418-09
NCGC00016418-10
NCGC00016418-11
NCGC00016418-12
NCGC00016418-14
NCGC00016418-15
NCGC00060938-02
NCGC00060938-03
NCGC00060938-04
NCGC00060938-05
NCGC00060938-06
NCGC00178871-01
NCGC00178871-02
NCGC00178871-03
NCGC00256435-01
NCGC00259316-01
NCI-C55903
NCI60_004085
New-Meladinin
NINDS_000763
NSC 45923
NSC-45923
NSC-757114
NSC45923
NSC757114
O-methylxanthotoxol
Oprea1_166319
Oxoralen
Oxsoralen
OXSORALEN (TN)
Oxsoralen lotion
Oxsoralen Ul tra
Oxsoralen Ultra
Oxsoralen-ultra
Oxypsoralen
Pharmakon1600-01500400
Prestwick_661
Prestwick0_000479
Prestwick1_000479
Prestwick2_000479
Prestwick3_000479
Proralone-mop
Psoralen-mop
Psoralon-MOP
Puvalen
Puvamet
Q-100381
Q039
QXKHYNVANLEOEG-UHFFFAOYSA-N
s1952
SAM002548974
SAM002564221
SBB005950
SBI-0051443.P003
SC-13812
SCHEMBL19168
SDCCGMLS-0042377.P002
SMR000071170
SPBio_001004
SPBio_002557
Spectrum_001023
SPECTRUM1500400
Spectrum2_001052
Spectrum3_000499
Spectrum4_000052
Spectrum5_001891
SR-01000629727
SR-01000629727-2
SR-01000629727-4
ST041029
ST24045871
STK735539
SW167762-4
Tox21_110432
Tox21_110432_1
Tox21_201767
Tox21_302816
U4VJ29L7BQ
Ultra Mop
Ultramop Lotion
UNII-U4VJ29L7BQ
Uvadex
UVADEX (TN)
Vitpso
WLN: T C566 DO LVOJ BO1
XANTHOTOXIN
Xanthotoxin, analytical standard
Xanthotoxin;Metoxaleno; Dltasoralen;Meladinine;Uvadex,;Oxsoralen
Xanthotoxine
Z1258578369
Zanthotoxin
ZINC2548959

US Patents and Regulatory Information for methoxsalen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt Hosp UVADEX methoxsalen INJECTABLE;INJECTION 020969-001 Feb 25, 1999 RX Yes Yes   Start Trial   Start Trial   Start Trial
Strides Pharma METHOXSALEN methoxsalen CAPSULE;ORAL 202687-001 Jun 5, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Inc METHOXSALEN methoxsalen CAPSULE;ORAL 202603-001 Jun 9, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Valeant Pharm Intl OXSORALEN methoxsalen LOTION;TOPICAL 009048-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for methoxsalen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch OXSORALEN-ULTRA methoxsalen CAPSULE;ORAL 019600-001 Oct 30, 1986   Start Trial   Start Trial
Mallinckrodt Hosp UVADEX methoxsalen INJECTABLE;INJECTION 020969-001 Feb 25, 1999   Start Trial   Start Trial
Mallinckrodt Hosp UVADEX methoxsalen INJECTABLE;INJECTION 020969-001 Feb 25, 1999   Start Trial   Start Trial
Mallinckrodt Hosp UVADEX methoxsalen INJECTABLE;INJECTION 020969-001 Feb 25, 1999   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Merck
Mallinckrodt
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.